FBAR Penalties Could Be Lessened Under New IRS Guidelines

According to the IRS, “if you have a financial interest in or signature authority over a foreign financial account, including a bank account, brokerage account, mutual fund, trust, or other type of foreign financial account, exceeding certain thresholds, the Bank Secrecy Act may require you to report the account yearly to the Department of Treasury by electronically filing a Financial Crimes Enforcement Network (FinCEN) 114, Report of Foreign Bank and Financial Accounts (FBAR).”
In other words, anyone who has money in a foreign bank account that exceeds $10,000 at any time during a given year will need to report that income to the IRS via an FBAR. However, recently, the IRS issued some new guidance regarding the penalties for those who don’t file an FBAR. According to reports, the IRS released a statement that noted: “For each year for which it is determined that there was a willful violation, examiners must fully develop and adequately document in the examination work papers their analysis regarding willfulness.”
For any case that involves willful violation for several years, it is up to the examiner to recommend the penalty length for each year the violation was determined to be willful. The IRS stated that typically the total penalty for the combined years under examination would not exceed ‘50 percent of the highest aggregate balance of all unreported foreign financial accounts during the years under examination.”
Meantime, an examiner can recommend more or less than the 50 percent threshold, but the total penalty cannot “exceed 100 percent of the highest aggregate balance.” There are obviously many possible scenarios and each case will be treated separately on its own merits and circumstances. The bottom line is you should still report your FBARs each year and report them on time. If you need help planning for and filing your FBAR then contact GROCO today at 1-877-CPA-2006, or by clicking here.
How Ellipsis Health Will Change Behavioral Health Diagnosis | Steven Cupps
AlanI’m visiting here today with Steven Cupps, he is the head of Business Development for Ellipsis Health. Welcome to today’s show.Steven Thank you so much for having me.AlanSo Steven, I’d like to hear the background of how you got to the position that you’re in today. What led up to this?StevenBehavioral health has always been a passion of mine. If you think about the entire ecosystem, and in healthcare, it’s really the biggest unmet challenge today. And so what we’re doing at ellipsis is we’re
California LLC Laws And IRS Identity Theft Reporting
A discussion on the tax history of LLC entities i…
Armin Tahmasbi | Encapsulate
I’m a young entrepreneur and a Ph.D. candidate in Biomedical Engineering program at the University of Connecticut, working on “Drug Delivery Systems, Self-Assembled Nanoparticles & Microfluidic Devices”, in Storrs, CT, US. I’m working in Self-Assembled Functional Nanomaterials Laboratory, under the supervision of Prof. Mu-Ping Nieh on “Drug Delivery Systems for cancer therapy”. We’re developing a universal platform for encapsulating and smart delivery of a wide range of drug molecules and
Spencer Jones | Lineus Medical
Spencer worked for 3 years in direct patient care as a Certified Nursing Assistant, Licensed Practical Nurse, and as a Registered Nurse. Frustrated with the inefficiencies plaguing the healthcare system, he was determined to play a role in improving the delivery of healthcare. In 2014, Spencer won the annual ARK Challenge, an Arkansas based business accelerator. The product he developed was a dual lumen peripheral IV called the BVAD, which focuses on painless and uncontaminated blood draws.